Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-29
2006-08-29
Kemmerer, Elizabeth (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S008100, C514S012200, C530S350000, C530S397000, C530S399000, C435S007210
Reexamination Certificate
active
07098183
ABSTRACT:
Aspects of the present invention relate to nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro. The present invention also concerns novel homodimeric and heterodimeric polypeptides and their use for altering mammalian ovarian follicular growth in vivo or in vitro.
REFERENCES:
patent: 6790824 (2004-09-01), Unsicker et al.
patent: 6872698 (2005-03-01), Marchionni et al.
patent: WO 00/32222 (2000-06-01), None
Stratagene 1991 Product Catalog. Prime-It Random Primer Labeling Kit, Cat. #300387.
Jaatinen et al. (1999), Mol. Cell. Endocrin. 156: 189-193.
Hsueh et al., Mol Cell Endocrinol. May 25, 2000; 163: 95-100.
Dube, J.L., 1998, “The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes”,Molecular Endocrinology, 12:1809-1817.
Davis George Henry
Galloway Susan May
Juengel Jennifer Lee
Laitinen Mika Petri Esaias
McNatty Kenneth Pattrick
Borgeest Christina
Kemmerer Elizabeth
Knobbe Martens Olson & Bear LLP
LandOfFree
Nucleotide and amino acid sequences of oocyte factors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleotide and amino acid sequences of oocyte factors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide and amino acid sequences of oocyte factors for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3710136